Yellow zone Nöroloji / Kronik Hastalık Yönetimi

Secondary Prevention After Stroke and Transient Ischemic Attack — A Transient Attack Is Not Relief, It Is a Warning, and No Undetected Rhythm Disorder Exists

There are TWO MAJOR ERRORS in secondary prevention after stroke. The FIRST is RELATED TO TIMING:

A PATIENT WHOSE SYMPTOMS RESOLVE ON THEIR OWN — THAT IS, A TRANSIENT ISCHEMIC ATTACK — IS CONSIDERED RELIEVING BY BOTH THE PATIENT AND THE PHYSICIAN, and the evaluation is postponed to an elective appointment. HOWEVER, the risk of recurrence is HIGHEST DURING THE FIRST FEW DAYS; A TRANSIENT ATTACK IS NOT RELIEF BUT A WARNING OF A POTENTIAL PERMANENT STROKE WITHIN A SHORT TIME and REQUIRES PROMPT EVALUATION.

The SECOND ERROR is DUE TO INCOMPLETE INVESTIGATION: PREVENTIVE TREATMENT CHOSEN WITHOUT DETERMINING THE CAUSE OF THE STROKE MAY BE INCORRECT.

The most commonly overlooked cause here is INTERMITTENT ATRIAL FIBRILLATION; this rhythm disorder often does not appear on a single electrocardiogram and short-term monitoring because it is transient. THIS DISTINCTION IS IMPORTANT BECAUSE TREATMENT CHANGES ENTIRELY:

IN STROKE CAUSED BY A RHYTHM DISORDER, ANTICOAGULANT THERAPY IS REQUIRED, WHILE IN STROKE DUE TO ARTERIAL HARDENING, ANTIPLATELET MEDICATION IS USED, and AN INCORRECT CHOICE LEAVES THE PATIENT UNPROTECTED. The THIRD POINT is THE SILENT DECLINE IN TREATMENT ADHERENCE OVER MONTHS.

The FOURTH POINT is THE HIGH FREQUENCY OF POST-STROKE DEPRESSION AND ITS DIRECT IMPACT ON RECOVERY. ALL DOSES SHOULD BE VERIFIED FROM INSTITUTIONAL PROTOCOLS.

Rapid management

  • A TRANSIENT ISCHEMIC ATTACK IS A WARNING, NOT RELIEF: because the symptoms resolve on their own, BOTH THE PATIENT AND THE DOCTOR RELAX and EVALUATION IS POSTPONED TO AN ELECTIVE APPOINTMENT → HOWEVER, THE PERIOD WHEN THE RISK OF RECURRENCE IS HIGHEST IS THE FIRST DAYS, AND PROMPT EVALUATION IS REQUIRED.
  • CHOSEN PREVENTIVE TREATMENT WITHOUT FINDING THE CAUSE MAY BE WRONG, AND THE MOST OFTEN MISSED CAUSE IS PAROXYSMAL ATRIAL FIBRILLATION: because this arrhythmia is TRANSIENT, IT IS OFTEN NOT DETECTED ON A SINGLE ELECTROCARDIOGRAM OR SHORT MONITORING → EXTENDED RHYTHM MONITORING SHOULD BE CONSIDERED IN STROKES OF UNKNOWN CAUSE; THE DURATION AND METHOD SHOULD BE CONFIRMED FROM INSTITUTIONAL PROTOCOL.
  • THE DIFFERENCE IS CRUCIAL because THE TREATMENT COMPLETELY CHANGES:
  • IN STROKE DUE TO ARRHYTHMIA, ANTI-COAGULANTS ARE USED, IN STROKE DUE TO VASCULAR STIFFNESS, ANTI-PLATELET AGENTS ARE USED (relevant protocol) → WRONG SELECTION LEAVES THE PATIENT UNPROTECTED.
  • OTHER CAUSES TO INVESTIGATE:
  • NARROWING OF NECK ARTERIES (the decision for intervention and its TIMING is important; DELAY REDUCES PROTECTIVE EFFECT), OTHER HEART-RELATED CAUSES, SMALL VESSEL DISEASE, ARTERY TEAR (in young patients, or with HISTORY OF NECK TRAUMA or SUDDEN NECK MOVEMENT), COAGULATION DISORDERS, and DETAILED EVALUATION IN YOUNG PATIENTS.
  • RISK FACTORS ARE MANAGED ACCORDING TO THE TARGET:
  • BLOOD PRESSURE (relevant protocol), BLOOD LIPIDS, DIABETES (relevant protocol), SMOKING, ALCOHOL, WEIGHT, SEDENTARY LIFESTYLE, and SLEEP APNEA (relevant protocol).
  • ADHERENCE TO TREATMENT QUIETLY DECLINES OVER MONTHS: as the patient IMPROVES, THEY CONSIDER THE MEDICATION UNNECESSARY → ASK ABOUT MISSED DOSES and EXPLAIN CONCRETELY WHAT THE MEDICATION PREVENTED.
  • IN THOSE USING ANTI-COAGULANTS, STOPPING THE MEDICATION DUE TO FEAR OF BLEEDING IS FREQUENT AND DANGEROUS; THE DECISION TO STOP DURING DENTAL OR SURGICAL PROCEDURES BELONGS TO THE DOCTOR.
  • POST-STROKE DEPRESSION IS VERY COMMON, DIRECTLY AFFECTS RECOVERY AND ADHERENCE, and MAY BE OVERLOOKED UNLESS ASKED ABOUT (relevant protocol).
  • ALSO TO BE ASSESSED:
  • DIFFICULTY SWALLOWING (relevant protocol), FALLS, SPASTICITY AND PAIN, URINARY PROBLEMS, VISUAL FIELD LOSS, COGNITIVE IMPAIRMENT (relevant protocol), DRIVING, and RETURN TO WORK.
  • REHABILITATION SHOULD START EARLY.
  • IN CASE OF NEW SYMPTOMS, THE PATIENT MUST SEEK IMMEDIATE ATTENTION, and THIS SHOULD BE COMMUNICATED IN WRITING.
  • ALL DOSES SHOULD BE CONFIRMED FROM THE INSTITUTIONAL PROTOCOL.
DrugAdultPediatricRouteDuration
A TRANSIENT ATTACK IS A WARNING — it should not be postponed Finding a transient attack relieving is the most costly mistake in this field. The patient's arm has been weak for a few minutes, his speech is disturbed, and then he improves; there are no findings on examination. This picture is good news for both the patient and the physician, and the natural outcome is to leave the examination to a calm day. However, what has happened is this: a vessel supplying the brain has been blocked for a short time and then opened spontaneously. The reason that caused the blockage has not disappeared; the same vessel can be blocked again in a few days, this time permanently. The period with the highest risk of recurrence is precisely these first few days. Therefore, the resolution of symptoms is not a guarantee but a short time window obtained. A PATIENT WHOSE SYMPTOMS RESOLVE SPONTANEOUSLY IS FOUND RELIEVING BOTH BY HIMSELF AND THE PHYSICIAN, and THE EVALUATION IS POSTPONED TO AN ELECTIVE APPOINTMENT. HOWEVER, THE PERIOD WITH THE HIGHEST RISK OF RECURRENCE IS THE FIRST FEW DAYS: A TRANSIENT ATTACK IS A WARNING OF A PERMANENT STROKE THAT MAY OCCUR IN A SHORT TIME and REQUIRES URGENT EVALUATION. IT SHOULD BE CLEARLY TOLD TO THE PATIENT: "THE FACT THAT IT HAS PASSED IS NOT GOOD NEWS; YOUR BODY HAS GIVEN YOU A WARNING." SCOPE OF EVALUATION: IMAGING, NECK VESSELS, HEART RHYTHM, BLOOD PRESSURE, BLOOD SUGAR, AND BLOOD LIPIDS. PROTECTIVE TREATMENT SHOULD BE STARTED WITHOUT DELAY; THE CHOICE AND TIMING SHOULD BE VERIFIED BY INSTITUTIONAL PROTOCOL Stroke in children occurs for different reasons and requires a specialized center — The first hours and days
NO UNDETECTED ARRHYTHMIA IS FOUND Missing intermittent atrial fibrillation leads to completely wrong treatment selection. The patient is admitted, the rhythm is monitored and found to be regular; the electrocardiogram is normal. With this information, the stroke is attributed to arteriosclerosis, and an antiplatelet drug is started. However, this arrhythmia does not occur continuously; it may not appear for days or weeks, and the patient may not feel palpitations. Failure to detect it in a short monitoring window does not mean it is absent. The distinction is important because the two treatments are not interchangeable; an antiplatelet is insufficient against a clot formed in the heart. As a result, the patient remains unprotected while being aware of taking medication, and a second stroke is often more severe. THE MOST COMMONLY MISSED CAUSE IS INTERMITTENT ATRIAL FIBRILLATION: This rhythm disorder is TRANSIENT, so it IS NOT SEEN IN A SINGLE ELECTROCARDIOGRAM AND SHORT-TERM MONITORING MOST OF THE TIME; the patient MAY NOT REPORT PALPITATIONS. In stroke of unknown cause, EXTENDED RHYTHM MONITORING should be considered; DURATION AND METHOD SHOULD BE VERIFIED BY INSTITUTIONAL PROTOCOL. THE DIFFERENCE IS CRUCIAL because THE TREATMENT ENTIRELY CHANGES: In stroke due to rhythm disorder, ANTICOAGULANT TREATMENT IS REQUIRED, while in stroke due to arterial stiffness, ANTIPLATELET AGENTS are used (relevant protocol) → WRONG CHOICE LEAVES THE PATIENT UNPROTECTED. EVEN IF RHYTHM MONITORING IS UNSUCCESSFUL, IF SUSPICION PERSISTS, MONITORING CAN BE REPEATED; THE DECISION BELONGS TO CARDIOLOGY AND NEUROLOGY. — — At the diagnostic stage
OTHER CAUSES and NECK VESSELS The importance of timing in narrowing of the neck vessel explains why the decision should not be postponed. When narrowing is detected, the option of intervention arises, and this evaluation is often postponed to a follow-up appointment after the patient is discharged; the patient appears stable, and there is no visible reason for urgency. However, the protective benefit provided by the intervention is time-dependent; the period with the highest benefit is the days immediately following the event because the risk of a second event is highest during this period. As weeks pass, the benefit decreases, and at some point, the risk of the intervention may exceed its benefit. Therefore, when narrowing is detected, the evaluation should not be delayed and urgent consultation with vascular surgery is needed. OTHER CAUSES TO INVESTIGATE: NARROWING IN THE NECK VESSELS — DECISION FOR INTERVENTION and ESPECIALLY TIMING is important because PROTECTIVE EFFECT IS HIGHEST IN THE EARLY PERIOD and DELAY REDUCES THIS EFFECT; OTHER CARDIAC CAUSES (valve diseases, intracardiac thrombus, hole — relevant protocols); SMALL VESSEL DISEASE; VASCULAR TEAR — SHOULD BE CONSIDERED IN YOUNG PATIENTS if ACCOMPANIED BY NECK PAIN or HEADACHE and there is a history of NECK TRAUMA, SUDDEN NECK MOVEMENT, or MANIPULATION; COAGULATION DISORDERS and INFLAMMATORY VASCULAR DISEASES. IN YOUNG PATIENTS AND WHEN THE CAUSE IS UNDETERMINED, EVALUATION SHOULD BE EXPANDED. PREGNANCY, POSTPARTUM PERIOD, and HORMONE USE should be questioned. Why the distribution of causes in children is completely different — At the diagnostic stage
RISK FACTORS ARE MANAGED ACCORDING TO THE TARGET The importance of blood pressure in secondary prevention indicates where monitoring should be focused. Post-stroke conversations mostly revolve around medication choice; detailed discussions occur about which blood thinner to use. This discussion is appropriate but not sufficient on its own. The only factor that contributes most to preventing a second stroke is bringing blood pressure to target, and this is more decisive than medication choice. However, blood pressure is measured in the outpatient clinic, found slightly high, and often deferred to the next visit. When the same delay is repeated at every check-up, years pass. Therefore, blood pressure should be addressed not as a subheading, but as the main topic of monitoring. TO BE MANAGED: BLOOD PRESSURE (the only most effective factor in secondary prevention — see relevant protocol), BLOOD LIPIDS, DIABETES (see relevant protocol), SMOKING CESSATION, REDUCTION OF ALCOHOL (see relevant protocol), WEIGHT, SALT, REGULAR EXERCISE, and SLEEP APNEA (see relevant protocol). TARGET VALUES and MEDICATION CHOICES SHOULD BE VERIFIED FROM THE INSTITUTIONAL PROTOCOL. When LOWERING BLOOD PRESSURE, CARE should be taken in the early period, especially in patients with SERIOUS NARROWING IN THE NECK ARTERIES; SPEED and TARGET are determined according to the SPECIALIST'S DECISION. THE PATIENT SHOULD BE INFORMED: THESE MEDICATIONS DO NOT RELIEVE SYMPTOMS, THEY PREVENT SECOND STROKE; THEREFORE, FEELING WELL IS NOT A REASON TO STOP THE MEDICATION. — — For life
COMPLIANCE QUIETLY DECLINES OVER MONTHS The silent decline in adherence is due to the fact that these medications do not relieve any complaints. A patient taking painkillers sees their effect and continues to use them; however, the medications here feel the same whether the patient feels well or poorly. As months pass, the memory of the stroke fades, the patient returns to work and routine, and the daily medications gradually begin to seem unnecessary. This thought forms not at a decision moment but gradually; first a dose is skipped, then a new one is not taken when the previous one ends. The patient does not tell their doctor about this because they do not think they have made a decision. Therefore, adherence should be asked not with a general question but with numbers, and what the medications prevent should be explained concretely at every check-up. COMPLIANCE WITH TREATMENT QUIETLY DECLINES OVER MONTHS because AS THE PATIENT IMPROVES, THEY SEE THE MEDICATION AS UNNECESSARY, and THESE MEDICATIONS DO NOT RELIEVE ANY SYMPTOM. THE QUESTION SHOULD BE ASKED IN NUMBERS: "HOW MANY DOSES DID YOU MISS IN THE LAST MONTH?" REASONS SHOULD BE ADDRESSED: SIDE EFFECTS, COST, MULTIPLE MEDICATIONS, FORGETTING, THE THOUGHT 'I AM FINE NOW', AND BLEEDING CONCERN. IN PATIENTS USING ANTICOAGULANTS, STOPPING THE MEDICATION ON THEIR OWN DUE TO BLEEDING CONCERN IS COMMON AND DANGEROUS; THE DECISION TO STOP DURING DENTAL EXTRACTION, ENDOSCOPY, AND SURGICAL INTERVENTIONS BELONGS TO THE DOCTOR, AND IN SOME PROCEDURES IT MAY NOT BE NECESSARY TO STOP. THE PATIENT SHOULD INFORM EVERY DOCTOR AND DENTIST ABOUT THE MEDICATION THEY ARE TAKING AND SHOULD CARRY A PORTABLE INFORMATION CARD. — — At every visit
POST-STROKE DEPRESSION and OTHER OUTCOMES Overlooking post-stroke depression directly slows recovery. During check-ups, discussions are about loss of strength, walking, and medications; the patient’s emotional state rarely comes up. Yet during this period, depression is very common, and only part of it is a natural reaction to experiences. The consequences are concrete: a depressed patient does not participate in rehabilitation, does not do exercises, and misses medications; thus both functional loss and recurrence risk increase. There is another factor complicating the diagnosis; a patient whose speech is affected cannot express emotions, and immobility is thought to be a remnant of the disease. Therefore, depression should be asked about directly, and if possible, information should also be obtained from a close person. POST-STROKE DEPRESSION IS VERY COMMON, DIRECTLY AFFECTS RECOVERY and TREATMENT ADHERENCE, and IS OVERLOOKED unless ASKED (relevant protocol); INFORMATION should ALSO BE GATHERED from close contacts because the patient may not be able to communicate due to SPEECH DIFFICULTY. ADDITIONALLY, the following SHOULD BE ASSESSED: SWALLOWING DIFFICULTY and ASPIRATION (relevant protocol), FALLS, MUSCLE SPASM and SHOULDER PAIN, URINARY and BOWEL PROBLEMS, VISUAL FIELD LOSS (for VEHICLE USE and FALL RISK), COGNITIVE IMPAIRMENT (relevant protocol), FATIGUE, SLEEP, and EMOTIONAL FLUCTUATIONS. REHABILITATION should begin EARLY and BE MAINTAINED. VEHICLE USE and RETURN TO WORK should also be assessed, and LEGAL REGULATIONS should be observed. THE BURDEN on CAREGIVERS should be asked. — — Throughout follow-up
SEEK ATTENTION WITHOUT WAITING FOR NEW SYMPTOMS Emphasizing that symptoms should not be waited on even if they pass determines access to treatment in a second event. The patient has previously experienced an attack that passed; this experience strengthens the tendency to wait with a new symptom. Waiting until morning to see a doctor in the outpatient clinic seems reasonable. However, the treatments that can open a blocked vessel are limited to a narrow time window, and if this window closes, permanent damage remains. For the same reason, the mode of transport is also important; if the patient travels by their own car, they lose time and the symptoms may progress on the way. This information should be given in writing at discharge and repeated at each follow-up. NEW SYMPTOMS should be GIVEN IN WRITING to the PATIENT and THEIR RELATIVE: FACIAL DROOP ON ONE SIDE, SUDDEN WEAKNESS OR NUMBNESS IN ARM OR LEG, TROUBLE SPEAKING OR UNDERSTANDING, SUDDEN VISION LOSS, SUDDEN SEVERE HEADACHE, SUDDEN LOSS OF BALANCE. IT SHOULD BE EMPHASIZED: SYMPTOMS SHOULD NOT BE WAITED OUT EVEN IF THEY PASS and EMERGENCY CARE SHOULD BE SOUGHT; 'IT PASSED, I’LL GO IN THE MORNING' IS THE MOST COMMON AND MOST HARMFUL DECISION because the TIME WINDOW FOR CLOTTING-DISSOLVING AND INTERVENTIONAL TREATMENTS IS NARROW (relevant protocol). A TRANSPORT PLAN SHOULD ALSO BE MADE: EMERGENCY SERVICES SHOULD BE CALLED INSTEAD OF GOING BY OWN CAR OR DRIVING. In patients living alone, the communication plan should also be addressed The same information should be provided to the family — During discharge and at each follow-up

Alternative

  • Migraine aura can be confused with temporary symptoms (relevant protocol).
  • Postictal temporary weakness should be differentiated (relevant protocol).
  • Low blood sugar can mimic a stroke-like presentation (relevant protocol).
  • Brain hemorrhage is differentiated through imaging (relevant protocol).
  • Syncope and vertigo are in the differential diagnosis (relevant protocols).
  • Peripheral vestibular disorders cause imbalance (relevant protocol).
  • Peripheral nerve compressions can be confused with numbness.
  • Brain tumors and hemorrhages should be considered in a progressive presentation.
  • During infection, old findings may reappear.
  • Functional neurological disorders are a separate category.

Red flags

  • Postponing a transient ischemic attack by saying 'get well soon' → the patient's arm was WEAK FOR A FEW MINUTES, SPEECH WAS IMPAIRED, and then it RECOVERED; THERE ARE NO FINDINGS IN THE EXAMINATION → THIS IS GOOD NEWS FOR BOTH THE PATIENT AND THE DOCTOR, and THE NATURAL CONSEQUENCE IS TO LEAVE THE EXAMINATION FOR A CALM DAY. HOWEVER, WHAT HAPPENED IS THIS: a vessel supplying the brain was BLOCKED FOR A SHORT TIME and OPENED BY ITSELF; THE CAUSE OF THE BLOCKAGE HAS NOT DISAPPEARED, and THE SAME VESSEL CAN BE BLOCKED AGAIN WITHIN A FEW DAYS, THIS TIME PERMANENTLY → THE PERIOD WHEN THE RISK OF RECURRENCE IS HIGHEST IS EXACTLY THESE FIRST DAYS.
  • Excluding atrial fibrillation because a single electrocardiography and short monitoring were normal → this arrhythmia DOES NOT SHOW CONTINUITY, it MAY NOT APPEAR FOR DAYS or WEEKS, and the patient MAY NOT FEEL PALPITATIONS → NOT CATCHING IT IN A SHORT MONITORING WINDOW DOES NOT MEAN IT IS NOT PRESENT.
  • Choosing the wrong preventive treatment → THE TWO TREATMENTS DO NOT REPLACE EACH OTHER: A PLATELET INHIBITOR IS INSUFFICIENT AGAINST THE CLOT FORMED IN THE HEART → the patient REMAINS UNPROTECTED KNOWING THEY ARE TAKING MEDICATION, and THE SECOND STROKE IS OFTEN MORE SEVERE.
  • Postponing evaluation for carotid artery stenosis → the patient SEEMS STABLE, and THERE IS NO OBVIOUS URGENT REASON; however, THE PROTECTIVE BENEFIT OF THE PROCEDURE IS TIME-DEPENDENT and THE HIGHEST PERIOD IS THE DAYS IMMEDIATELY AFTER THE EVENT → AS WEEKS PASS, THE BENEFIT DECREASES, and AFTER A POINT, THE RISK OF THE PROCEDURE MAY OUTWEIGH ITS BENEFIT.
  • Not expanding evaluation in a young patient or in cases with no identified cause; not considering arterial tear in the history of neck pain and trauma.
  • Finding blood pressure 'a little high' and postponing to the next check-up → post-stroke discussions are MOSTLY BASED ON MEDICATION SELECTION and THIS DISCUSSION IS APPROPRIATE; however, IT ALONE IS NOT SUFFICIENT: THE SINGLE MOST IMPORTANT FACTOR IN PREVENTING A SECOND STROKE IS BRINGING BLOOD PRESSURE TO TARGET, and THIS IS MORE DETERMINATIVE THAN MEDICATION SELECTION → WHEN THE SAME DELAY IS REPEATED IN EVERY CHECK-UP, YEARS PASS.
  • Rapid lowering of blood pressure in the early period and in severe carotid artery stenosis.
  • CHECKING COMPLIANCE WITH A GENERAL QUESTION → these drugs DO NOT RELIEVE ANY COMPLAINTS: THE PATIENT FEELS THE SAME WHEN HE IS WELL OR BAD | As the months pass, the memory of the stroke becomes blurred, the patient RETURNS TO WORK AND ROUTINE, and the medications he takes every day begin to seem increasingly unnecessary, → THIS THOUGHT OCCURS GRADUALLY, NOT AT THE MOMENT OF A DECISION: FIRST THE DOSE IS SKIPPED, THEN A NEW ONE IS NOT TAKEN WHEN IT IS OVER, AND THE PATIENT DOES NOT TELL THIS TO HIS PHYSICIAN BECAUSE HE DOES NOT THINK THAT HE HAS MADE A DECISION HIMSELF.
  • THE DECISION TO CUT THE ANTICOAGULANT ON ITS OWN → TOOTH EXTRACTION, ENDOSCOPY AND SURGICAL INTERVENTIONS DUE TO BLEEDING CONCERNS BELONGS TO THE PHYSICIAN and SOME INTERVENTIONS DO NOT REQUIRE CUTTING.
  • NOT ASKING ABOUT POST-STROKE DEPRESSION → what is discussed in the controls are LOSS OF STRENGTH, WALKING and MEDICATIONS; MENTAL STATE RARELY COMES TO THE FORE | The results are tangible: the depressed patient DOES NOT PARTICIPATE IN REHABILITATION, DOES NOT EXERCISE AND DISRUPTS HIS MEDICATIONS → BOTH LOSS OF FUNCTION AND THE RISK OF RELAPSE INCREASE | There is another situation that makes diagnosis difficult: THE PATIENT WHOSE SPEECH IS AFFECTED CANNOT EXPRESS HIS FEELINGS and HIS INACTIVITY IS THOUGHT TO BE A REMNANT OF THE DISEASE.
  • Failure to assess DIFFICULTY SWALLOWING, FALLS, VISUAL FIELD LOSS, and COGNITIVE IMPAIRMENT.
  • IN → NEW SYMPTOM "IT'S GONE, I'LL GO IN THE MORNING" decision, THE PATIENT HAS EXPERIENCED AN ATTACK BEFORE and SAW IT PASS; THIS EXPERIENCE REINFORCES THE TENDENCY TO WAIT, → WHEREAS THE TIME THAT TREATMENTS THAT ALLOW THE OPENING OF A BLOCKED VESSEL CAN BE APPLIED IS LIMITED TO A NARROW WINDOW, AND WHEN THIS WINDOW CLOSES, PERMANENT DAMAGE TO THE HAND REMAINS (relevant protocol).
  • WHEN THE PATIENT SETS OFF WITH HIS OWN CAR → NOT TALKING ABOUT THE TRANSPORTATION PLAN, HE BOTH LOSES TIME AND MAY PROGRESS ON THE ROAD.
  • Delaying REHABILITATION and not asking about the BURDEN OF CAREGIVER.

Disposition and follow-up

Green zone
The cause has been determined, preventive treatment has been initiated, risk factors are targeted, functionality has been preserved: planned control, compliance and blood pressure monitoring, continuation of rehabilitation.
Yellow zone
Unexplained stroke and the need for extended rhythm monitoring, stenosis in the neck vessel, blood pressure or blood fats that do not reach the target, medication non-compliance, post-stroke depression, difficulty swallowing, increased falls, vehicle use and return to work evaluation: urgent neurology and related unit evaluation.
Red zone
Newly emerging facial droop, weakness in the arm or leg, speech impairment, sudden vision loss, sudden loss of balance — even if the symptoms have passed: urgent evaluation (relevant protocol). Sudden and most severe headache of life: urgent evaluation (relevant protocol). Head trauma, severe headache, bleeding, or black stool in a patient using anticoagulants: urgent evaluation (relevant protocol). Signs of inability to swallow and choking: urgent evaluation. Seizure: urgent evaluation (relevant protocol). Fever and change in consciousness: urgent evaluation (relevant protocol). Suicidal thoughts: urgent psychiatry (relevant protocol).

Key clinical points

READ FIRST — transient attack is a warning, the rhythm sought is not found

THE REASSURING FINDING OF A TRANSIENT ISCHEMIC ATTACK — THE MOST COSTLY MISTAKE IN THIS AREA | The patient's arm has been WEAK FOR A FEW MINUTES, SPEECH IMPAIRED, and THEN RECOVERED; THERE ARE NO FINDINGS ON EXAMINATION | THIS SCENARIO IS GOOD NEWS FOR BOTH THE PATIENT AND THE DOCTOR and THE NATURAL CONSEQUENCE IS TO LEAVE THE EXAMINATION FOR A CALM DAY | HOWEVER, WHAT HAS HAPPENED IS THIS: A VESSEL SUPPLYING THE BRAIN WAS TEMPORARILY BLOCKED AND THEN OPENED ON ITS OWN | THE REASON CAUSING THE BLOCKAGE HAS NOT BEEN REMOVED: THE SAME VESSEL MAY BLOCK AGAIN WITHIN A FEW DAYS, AND THIS TIME PERMANENTLY | THE PERIOD OF HIGHEST RISK OF RECURRENCE IS EXACTLY THESE FIRST DAYS → PASSING SYMPTOMS IS NOT A GUARANTEE, BUT A SHORT TIME GAINED | WHAT TO TELL THE PATIENT: 'THE SYMPTOMS PASSING IS NOT GOOD NEWS; YOUR BODY HAS GIVEN YOU A WARNING' | URGENT EVALUATION INCLUDES: IMAGING | NECK VESSELS | HEART RHYTHM | BLOOD PRESSURE | BLOOD SUGAR AND BLOOD LIPIDS | THE RHYTHM SOUGHT IS NOT FOUND — THIS LEADS TO ENTIRELY WRONG TREATMENT | The patient is admitted to bed, RHYTHM MONITORED, and FOUND REGULAR; ELECTROCARDIOGRAPHY IS NORMAL → with this information, the stroke is ATTRIBUTED TO ARTERIAL HARDENING and ANTI-PLATELET THERAPY IS STARTED | HOWEVER, THIS RHYTHM DISTURBANCE DOES NOT SHOW CONTINUITY: FOR DAYS or WEEKS MAY NOT APPEAR and the PATIENT MAY NOT FEEL PALPITATIONS → NOT CATCHING IT IN A SHORT MONITORING WINDOW DOES NOT MEAN IT IS ABSENT | THE DISTINCTION IS IMPORTANT because THE TWO TREATMENTS ARE NOT INTERCHANGEABLE: PLATELET INHIBITORS ARE INSUFFICIENT AGAINST CLOTS FORMED IN THE HEART | AS A RESULT, THE PATIENT REMAINS UNPROTECTED KNOWING THEY ARE TAKING MEDICATION, and THE SECOND STROKE IS OFTEN MORE SEVERE | RULE: IN STROKES OF UNKNOWN CAUSE, EXTENDED RHYTHM MONITORING IS CONSIDERED; DURATION and METHOD ARE VERIFIED FROM THE INSTITUTIONAL PROTOCOL | EVEN IF MONITORING IS UNSUCCESSFUL, IF SUSPICION PERSISTS, IT CAN BE REPEATED | OTHER CAUSES TO INVESTIGATE: NARROWING OF NECK ARTERIES | CARDIAC ORIGIN CAUSES | SMALL VESSEL DISEASE | VESSEL DISSECTION (young patient + neck/head pain + trauma or sudden neck movement) | COAGULATION DISORDERS

A transient ischemic attack is reassuring because there are no findings on examination; however, the cause of the blockage has not been resolved, and the risk of recurrence is highest in the initial days. Paroxysmal atrial fibrillation is not seen on a single electrocardiogram, and not catching it in a short window does not mean it is absent; the distinction is decisive because platelet inhibitors are insufficient against clots formed in the heart, and the patient remains unprotected knowing they are taking medication.

Timing, blood pressure, silent compliance loss, and depression

TIMING IN CAROTID ARTERY NARROWING — DECISION CANNOT BE POSTPONED | When narrowing is detected, the INTERVENTION OPTION COMES ON THE AGENDA and this evaluation is MOST OFTEN LEFT TO AN APPOINTMENT AFTER THE PATIENT IS DISCHARGED: the patient APPEARS STABLE and THERE IS NO OBVIOUS REASON TO HURRY | HOWEVER, THE PROTECTIVE BENEFIT PROVIDED BY THE INTERVENTION IS TIME-DEPENDENT: THE PERIOD WHEN IT IS HIGHEST IS THE DAYS IMMEDIATELY FOLLOWING THE EVENT because THE RISK OF A SECOND EVENT IS HIGHEST DURING THIS PERIOD | AS WEEKS PASS, THE BENEFIT THAT CAN BE OBTAINED DECREASES and AFTER A POINT THE RISK OF THE INTERVENTION MAY OUTWEIGH ITS BENEFIT → EVALUATION SHOULD NOT BE DELAYED | BLOOD PRESSURE IS THE ONLY FACTOR MOST EFFECTIVE IN SECONDARY PROTECTION | Post-stroke discussions MOSTLY FOCUS on MEDICATION SELECTION: WHICH BLOOD THINNER TO USE IS DISCUSSED IN DETAIL | THIS DISCUSSION IS APPROPRIATE BUT ALONE IS NOT SUFFICIENT: THE SINGLE MOST CONTRIBUTIVE FACTOR IN PREVENTING A SECOND STROKE IS TARGETING BLOOD PRESSURE, and THIS IS MORE DETERMINATIVE THAN MEDICATION SELECTION | HOWEVER, blood pressure IS MEASURED IN THE OUTPATIENT CLINIC, FOUND TO BE SLIGHTLY HIGH, and MOST OFTEN LEFT TO THE NEXT CHECK-UP → WHEN THE SAME POSTPONEMENT REPEATS AT EACH CHECK-UP, YEARS PASS | RULE: blood pressure IS NOT A SIDE TOPIC, IT IS THE MAIN SUBJECT OF MONITORING | IN THE EARLY PERIOD AND IN SEVERE CAROTID ARTERY NARROWING, THE RATE OF LOWERING IS DETERMINED CAREFULLY | COMPLIANCE QUIETLY DECREASES OVER MONTHS — THESE MEDICATIONS DO NOT RELIEVE ANY SYMPTOMS | A patient taking painkillers SEES THE EFFECT and CONTINUES TO USE THEM; THESE MEDICATIONS, HOWEVER, MAKE THE PATIENT FEEL THE SAME WHETHER WELL OR ILL | As months pass, the MEMORY OF THE STROKE FADES, the patient RETURNS TO WORK AND ROUTINE, and THE MEDICATIONS TAKEN DAILY GRADUALLY START TO SEEM UNNECESSARY | THIS THINKING DOES NOT DEVELOP AT THE MOMENT OF DECISION, IT DEVELOPS GRADUALLY: FIRST A DOSE IS SKIPPED, THEN WHEN FINISHED, THE NEXT IS NOT TAKEN | THE PATIENT DOES NOT TELL THIS TO THE DOCTOR because THEY DO NOT THINK THEY ARE MAKING A DECISION → ASK WITH NUMBERS: "HOW MANY DOSES DID YOU MISS IN THE LAST MONTH?" and WHAT THE MEDICATIONS PREVENT IS REEXPLAINED AT EACH CHECK-UP: "THESE MEDICATIONS DO NOT RELIEVE SYMPTOMS, THEY PREVENT A SECOND STROKE" | ANTICOAGULANTS ARE NOT STOPPED ALONE DUE TO BLEEDING CONCERNS: DECISIONS ABOUT DENTAL EXTRACTION, ENDOSCOPY, AND SURGERY BELONG TO THE DOCTOR, and IN SOME INTERVENTIONS, STOPPING IS NOT REQUIRED → THE PATIENT TELLS EVERY DOCTOR AND DENTIST ABOUT THE MEDICATION, AND CARRIES AN INFORMATION CARD | POST-STROKE DEPRESSION GOES UNNOTICED AND DIRECTLY SLOWS RECOVERY | Discussions at check-ups are ABOUT WEAKNESS, WALKING, AND MEDICATIONS; THE PATIENT'S MENTAL STATE RARELY COMES UP | HOWEVER, depression IS VERY COMMON during this period and ONLY PART OF IT IS A NATURAL REACTION TO WHAT HAPPENED | THE RESULTS ARE TANGIBLE: THE DEPRESSED PATIENT DOES NOT PARTICIPATE IN REHABILITATION, DOES NOT EXERCISE AND SKIPS HIS MEDICATIONS → BOTH LOSS OF FUNCTION AND THE RISK OF RELAPSE INCREASE | THERE IS ANOTHER SITUATION THAT MAKES DIAGNOSIS DIFFICULT: THE PATIENT WHOSE SPEECH IS AFFECTED CANNOT EXPRESS HIS FEELINGS AND HIS INACTIVITY IS THOUGHT TO BE A REMNANT OF THE DISEASE → ASKED DIRECTLY AND, IF POSSIBLE, INFORMATION IS OBTAINED CLOSELY (relevant protocol) | ALSO: DIFFICULTY SWALLOWING | FALLS | CONTRACTION and SHOULDER PAIN | URINARY PROBLEMS | VISUAL FIELD LOSS | COGNITIVE IMPAIRMENT | FATIGUE | VEHICLE USE and RETURN TO WORK | CAREGIVER LOAD | NOT EXPECTED IN A NEW SYMPTOM — "IT'S LATE, I'LL GO IN THE MORNING" IS THE MOST HARMFUL DECISION | The patient has HAD AN ATTACK BEFORE AND SAW IT GO AWAY: THIS EXPERIENCE REINFORCES THE TENDENCY TO WAIT | HOWEVER, THE TIME THAT TREATMENTS THAT OPEN A BLOCKED VESSEL CAN BE APPLIED IS LIMITED TO A NARROW WINDOW AND WHEN THIS WINDOW IS CLOSED, PERMANENT DAMAGE REMAINS ON THE HAND | TRANSPORTATION IS ALSO IMPORTANT: WHEN THE PATIENT SETS OFF WITH HIS OWN CAR, HE LOSES TIME AND MAY PROGRESS ON THE ROAD → IS CALLED URGENTLY | THE LIST IS GIVEN IN WRITING AT DISCHARGE AND REPEATED AT EACH CONTROL

The benefit of intervention in neck vein stenosis depends on time and decreases as the weeks pass, so the evaluation is not postponed. Blood pressure is the single most effective factor in secondary prevention, but it is left to the next at each check-up. Compliance falls silently because these drugs do not relieve any complaints and the patient does not even think that he has made a decision. Post-stroke depression impairs participation in rehabilitation and medication adherence; Inactivity in the patient whose speech is affected is thought to be a remnant of the disease.

Featured external sources

Detailed assessment

Diagnostic and decision reasoning

Clinical framework

Overview

There are two major mistakes in secondary prevention after stroke. The first is related to timing: in the patient whose symptoms go away spontaneously, the evaluation is delayed, whereas the risk of recurrence is highest in the first days and a transient attack is a warning of a permanent stroke.

The second is that the cause research is left incomplete; The most missed cause is intermittent atrial fibrillation and is considered excluded because it is not seen on a single electrocardiography. The difference is decisive because while anticoagulants are required in stroke due to arrhythmia, platelet blockers are used in those due to atherosclerosis.

Blood pressure is the single most effective factor in secondary prevention. Compliance with treatment falls silently within months.

Depression after stroke is very common and directly affects recovery.

Differential diagnosis and assessment

Key considerations

  • Migraine aura can be confused with temporary symptoms (relevant protocol).
  • Postictal temporary weakness should be differentiated (relevant protocol).
  • Low blood sugar can mimic a stroke-like presentation (relevant protocol).
  • Brain hemorrhage is differentiated through imaging (relevant protocol).
  • Syncope and vertigo are in the differential diagnosis (relevant protocols).
  • Peripheral vestibular disorders cause imbalance (relevant protocol).
  • Peripheral nerve compressions can be confused with numbness.
  • Brain tumors should be considered in the progressive picture.
  • During infection, old findings may reappear.
  • Functional neurological disorders are a separate category.

Clinical decision reasoning

Why it matters

In this field, the points that determine the outcome are timing, investigation of the cause, and continuity. The first point is that a transient attack should be a warning and not postponed.

The second point is that paroxysmal atrial fibrillation is not found unless searched for, and this distinction completely changes the treatment. The third point is that the benefit of intervention in carotid artery stenosis depends on time.

The fourth point is that blood pressure is the most effective single factor in secondary prevention. The fifth point is that adherence silently declines because these drugs do not relieve symptoms.

The sixth point is that post-stroke depression directly affects recovery. The final point is that a new symptom should not be expected.

Safety and monitoring

Complications and safety

Critical complications

  • Recurrent stroke is the most severe outcome.
  • Being unprotected occurs due to incorrect preventive treatment.
  • Bleeding can occur due to anticoagulant therapy (relevant protocol).
  • Aspiration and pneumonia can occur due to swallowing difficulties (relevant protocol).
  • Falls and fractures occur.
  • Post-stroke depression and anxiety develop (relevant protocols).
  • Muscle contraction, shoulder pain, and joint stiffness occur.
  • Seizures may develop after stroke (relevant protocol).
  • Cognitive impairment and vascular dementia develop (relevant protocol).
  • Job loss, inability to drive, and social withdrawal occur.

Special patient populations

Special considerations

  • In young patients, the investigation of cause should be expanded, and vascular dissection should be considered.
  • In those with atrial fibrillation, anticoagulation is planned (relevant protocol).
  • In those who have had a brain hemorrhage, the preventive decision is different (relevant protocol).
  • In kidney failure, the choice and dose of medication change (relevant protocol).
  • In the elderly, fall risk and drug interactions are also monitored.
  • Evaluation during pregnancy and postpartum is the responsibility of the specialist center.
  • In those with diabetes, targets are considered together (relevant protocol).
  • In those with sleep apnea, treatment is part of secondary prevention (relevant protocol).
  • In patients living alone, a communication and transport plan is also made.

Follow-up and reassessment

Follow-up plan

Post-stroke follow-up should be based on the continuity of prevention. At each check-up, the number of missed doses should be asked, and what the medications prevent should be explained again.

Blood pressure monitoring should be considered the main focus, and if the target is not reached, it should not be postponed. Blood lipids, blood sugar, smoking, and alcohol should be evaluated regularly.

In patients with unknown cause, it should be verified whether rhythm monitoring has been performed. Post-stroke depression should be asked about directly and, if possible, information should be obtained closely.

Swallowing, falls, seizures, pain, urinary problems, visual field, and cognitive functions should be evaluated. Whether rehabilitation is continuing should be asked.

Driving and returning to work should be reassessed. For those using anticoagulants, it should be reminded that the decision to stop the medication before any intervention belongs to the physician.

Warning signs should be provided in writing; facial droop, weakness, speech disturbance, sudden vision loss, and sudden severe headache require immediate emergency admission even if they subside.

Structured references

  1. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke AssociationKleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al.Stroke · 2021 Jul PMID: 34024117
  2. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. AHA/ASA. Stroke. — ikincil korunma stratejileri, risk etkeni hedefleri, karotis girişim zamanlaması ve etiyolojik değerlendirme. Sürüm ve yıl kurumsal kütüphaneden teyit edilmeli. DOĞRULANMALI
  3. European Stroke Organisation (ESO) ikincil korunma ve geçici iskemik atak yönetimi kılavuzları. — ivedi değerlendirme, görüntüleme ve tedavi başlangıcının zamanlaması. Sürüm ve yıl kurumsal kütüphaneden teyit edilmeli. DOĞRULANMALI
  4. Kaynağı belirlenemeyen inmede uzatılmış kardiyak ritim izleminin atriyal fibrilasyon yakalama oranını inceleyen randomize çalışmalar ve meta-analizler. — tek EKG ile dışlamanın yetersizliği ve uzatılmış izlemin gerekçesi. Tam künyeler kurumsal kütüphaneden teyit edilmeli. DOĞRULANMALI
  5. Semptomatik karotis darlığında girişim zamanlaması ve gecikmenin koruyucu yararı azaltmasına ilişkin havuzlanmış analizler. — erken değerlendirmenin gerekçesi. Tam künyeler kurumsal kütüphaneden teyit edilmeli. DOĞRULANMALI
  6. İnme sonrası depresyonun sıklığı, iyileşme ve tedavi uyumu üzerindeki etkisi ile ikincil korunma ilaçlarına uzun dönem uyumu inceleyen çalışmalar. — çökkünlüğün sorgulanması ve uyum izleminin gerekçesi. Tam künyeler kurumsal kütüphaneden teyit edilmeli. DOĞRULANMALI

Last reviewed: 2026-08-06 · Review due: 2027-08-06

This protocol is intended solely as physician bedside DECISION SUPPORT and does not replace independent clinical judgment. DRUG NAMES and DOSAGES, BLOOD PRESSURE and LIPID TARGET VALUES, DURATION OF RHYTHM MONITORING, CAROTID NARROWING PERCENTAGE THRESHOLDS, PROCEDURE TIME WINDOWS, and TIMING FOR INITIATION OF ANTICOAGULANT THERAPY have not intentionally been provided; these vary based on the guideline version, the patient, and the center's practice and should be VERIFIED FROM INSTITUTIONAL PROTOCOLS AND THE NEUROLOGY AND CARDIOLOGY DEPARTMENTS. CRITICAL SAFETY: (1) A TRANSIENT ISCHEMIC ATTACK IS NOT RELIEF BUT A WARNING, and the period with the HIGHEST RISK OF RECURRENCE is the first days; (2) ATRIAL FIBRILLATION CANNOT BE EXCLUDED JUST BECAUSE A SINGLE ELECTROCARDIOGRAM IS NORMAL — IT MAY NOT BE SEEN SINCE IT IS INTERMITTENT; (3) ANTIPLATELET THERAPY ALONE IS INSUFFICIENT IN STROKE DUE TO RHYTHM DISORDER, leaving the PATIENT UNPROTECTED; (4) THE PROTECTIVE BENEFIT OF INTERVENTION IN CAROTID ARTERY STENOSIS DEPENDS ON TIMING and DELAY REDUCES THIS BENEFIT; (5) BLOOD PRESSURE IS THE MOST EFFECTIVE SINGLE FACTOR IN SECONDARY PROTECTION and is the MAIN FOCUS OF MONITORING; (6) IN EARLY STAGES AND IN SEVERE STENOSIS, THE RATE OF BLOOD PRESSURE REDUCTION SHOULD BE DETERMINED CAREFULLY; (7) COMPLIANCE SILENTLY DECLINES because THESE DRUGS DO NOT RELIEVE SYMPTOMS — QUESTIONS SHOULD BE ASKED ABOUT MISSED DOSES; (8) ANTICOAGULATION CANNOT BE STOPPED ON ITS OWN, and THE DECISION BEFORE INTERVENTION BELONGS TO THE PHYSICIAN; (9) DEPRESSION AFTER STROKE IS VERY COMMON, DISRUPTS REHABILITATION AND COMPLIANCE, and REMAINS UNSEEN IN PATIENTS WITH SPEECH IMPAIRMENT; (10) NEW SYMPTOMS SHOULD NOT BE EXPECTED TO PASS and EMERGENCY CALL IS REQUIRED. Acute ischemic stroke, brain hemorrhage, atrial fibrillation, and seizure protocols are separate. Content requires expert manual verification.